학술논문

Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation
Document Type
Article
Source
In: European Journal of Nuclear Medicine and Molecular Imaging. (European Journal of Nuclear Medicine and Molecular Imaging, April 2022, 49(5):1574-1583)
Subject
Language
English
ISSN
16197089
16197070